How to Buy Intensity Therapeutics Stock

Intensity Therapeutics Inc

Intensity Therapeutics, Inc. , a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors.

Intensity Therapeutics stock last closed at $0.24, up 0.83% from the previous day, and has decreased 94.05% in one year. It has underperformed other stocks in the Biotechnology industry by 0.46 percentage points. Intensity Therapeutics stock is currently +30.81% from its 52-week low of $0.19, and -94.21% from its 52-week high of $4.18.

At the moment, there are 47.06M INTS shares outstanding. The market value of INTS is $11.39M. In the last 24 hours, 1.46M INTS shares were traded.

How to Buy Intensity Therapeutics Stock

Wondering how to invest in Intensity Therapeutics stock? Here's how.

  1. Figure out where to buy Intensity Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Intensity Therapeutics stock.
  2. Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Fund your brokerage account: Choose your method of payment and add your info.
  4. Evaluate Intensity Therapeutics stock: The Intensity Therapeutics ticker symbol is INTS. Is Intensity Therapeutics stock a good investment? Should you buy shares of INTS? How do INTS's underlying business fundamentals look? Do top analysts think Intensity Therapeutics is a good buy? Why has INTS's stock price moved recently? (Hint: Our stock research website can help you understand if INTS is a good stock to buy).
  5. Make your INTS buy order: Decide if you will purchase INTS shares at the current market price or use a limit order to purchase INTS stock at a particular price.
  6. Get the latest scoop on your investment in INTS: Create a watchlist to track your new investment in Intensity Therapeutics stock.

Step 1: Figure out where to buy Intensity Therapeutics stock

You will need a brokerage account to access the NASDAQ market and buy INTS stock.

A brokerage account allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

In our opinion, eToro is the best brokerage. eToro gives you:

  • Invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world financial markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
  • Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've picked the right brokerage, the next step is to fill out some personal information so you can buy INTS stock today.

How to Create a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal details to start your new brokerage account.
  1. Send your details by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you've created your account on app for stock, your next step is to transfer the money for your investment:

Check out the tutorial below if you need help depositing funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Intensity Therapeutics stock

After you have figured out the best place to buy Intensity Therapeutics stock, it's very important to evaluate their stock before you buy, so you truly understand the risk as well as the upside.

Intensity Therapeutics shares quick numbers

INTS Price
$0.24
1w %
-5.47%
1y %
-94.05%
5y %
N/A
P/E
-0.3x
P/B
5.21x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$12.58M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$11.39M
Next Earnings
Nov 18, 2025
Next Dividend
N/A

Intensity Therapeutics Due Diligence Score

WallStreetZen was designed to help everyday investors perform more accurate fundamental analysis quickly.

You can view all of the due diligence checks on INTS's stock page.

How is INTS stock valued?

You can use many financial metrics, analyses, models, and charts to gauge INTS's true value.

Using relative valuations metrics:

  • INTS could be overvalued based on its P/B ratio of 5.21x, relative to Biotechnology industry P/B ratio of 4.69x

You can do more valuation research on INTS's stock here.

How do INTS Financials look?

Signs that INTS is financially healthy:

  • There are more short-term assets than long-term liabilities on the INTS balance sheet.
  • There are more short-term assets than short-term liabilities on the INTS balance sheet.

Signs that INTS is not financially healthy:

  • INTS has cash burn of 11085000. It does not have enough cash and short-term investments to cover this.
  • INTS has a relatively high debt to equity ratio of 1.03.
  • INTS has $2.22M in cash and short term investments. This is not sufficient to cover its annual cash burn of $11.09M.

Do Wall Street analysts think it's a good time to buy Intensity Therapeutics stock

Out of 2 sell side analysts who track INTS, the consensus analyst rating on INTS is a Strong Buy

It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.

You can dive deeper into what analysts are projecting on the Intensity Therapeutics stock forecast page.

INTS Trading Indicators

SMA10
0.26
SMA20
0.28
SMA50
0.29
SMA100
0.36
SMA200
1.26
MACD
-0.02
MACD Signal
-0.01
MACD Histogram
0
RSI
37.24
Stochastic %K
25.44
Stochastic %D
17.28
StochRSI %K
20.27
StochRSI %D
11.54

What are INTS insiders up to?

Over the last 12 months, insiders at INTS have bought more shares than they have sold.

Joseph Talamo, Chief Financial Officer of INTS, was the latest INTS insider to buy. They bought $3,700.72 worth of INTS shares on Jun 30, 2025.

Dig into more about who owns INTS shares here.

Can I get consistent income from INTS stock?

No, Intensity Therapeutics doesn't provide an income stream by paying out dividends.

What do other traders have to say about INTS?

One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other community members have to say.

Step 5: Make your INTS buy order

There are two main order types:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly fine.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to be certain you're buying or selling at a given price, use a limit order.

Click the Open Trade button and your broker will place your order.

If you require more help with buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get the latest scoop on your investment in INTS

Now that you own some INTS stock, you'll want to stay up-to-date on your stock purchase.

Add INTS to a watchlist to see the latest developments about your INTS stock.

INTS Feed

How to Buy Stock in Intensity Therapeutics

To summarize, here are the 6 steps for buying Intensity Therapeutics stock:

  1. Figure out where to buy Intensity Therapeutics stock
  2. Open a brokerage account
  3. Fund your brokerage account
  4. Evaluate Intensity Therapeutics stock
  5. Make your INTS buy order
  6. Get the latest scoop on your investment in INTS

If you need a brokerage, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get notifications regarding your new investment in Intensity Therapeutics, get started below.

NASDAQ: INTS
$0.24+0.00 (+0.83%)
Updated Sep 17, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: INTS
$0.24+0.00 (+0.83%)
Updated Sep 17, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Intensity Therapeutics share?

As of Sep 17, 2025, it costs $0.24 to buy one share of Intensity Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.12, you can buy 0.5 shares of INTS.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Intensity Therapeutics stock?

According to 2 Wall Street analysts who monitor Intensity Therapeutics, their consensus recommendation is to buy Intensity Therapeutics stock.

What is the best way to buy Intensity Therapeutics stock?

One way to place an order for Intensity Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.